Literature DB >> 23450170

Genital herpes in Canada: Deciphering the hidden epidemic.

Mubeen Aslam1, Rhonda Y Kropp, Gayatri Jayaraman, Katherine Dinner, Thomas Wong, Marc Steben.   

Abstract

INTRODUCTION: Genital herpes (GH) is the most common cause of genital ulceration, but is not reportable in Canada. Research in the United States has found that less than 10% of seropositive persons reported a diagnosis of GH. The present article investigates the rates of diagnosed cases of GH in Canada from 2002 to 2007.
METHODS: Primary case diagnosis data on GH for the period between 2002 and 2007 were obtained from the Canadian Disease and Therapeutic Index, a proprietary database maintained by Intercontinental Medical Statistics (IMS) Health Canada. Of the 45,000 to 49,000 office-based physicians in Canada, IMS Health collected diagnosis-specific prescription diaries from a sample of 652, stratified according to geographic region and representing all major specialties, during this period.
RESULTS: Between 2002 and 2007, there were approximately 84,398 to 122,456 medically attended GH cases annually in Canada. Approximately 74% to 93% of these diagnosed cases made one physician visit per year. The annual rate of medically attended GH cases ranged from 261.2 per 100,000 population to 386.6 per 100,000 population. DISCUSSION: The present report is the first time that administrative data have been used to estimate the annual rate of medically attended GH cases in Canada. The data include both incident and prevalent cases and are likely an underestimate of the actual number of cases because they only represent diagnosed cases presenting for medical care. Further seroepidemiological and clinical research studies would be helpful to assess the burden of infection and to plan appropriate diagnostic, treatment and preventive counselling services.
INTRODUCTION: Genital herpes (GH) is the most common cause of genital ulceration, but is not reportable in Canada. Research in the United States has found that less than 10% of seropositive persons reported a diagnosis of GH. The present article investigates the rates of diagnosed cases of GH in Canada from 2002 to 2007.
METHODS: Primary case diagnosis data on GH for the period between 2002 and 2007 were obtained from the Canadian Disease and Therapeutic Index, a proprietary database maintained by Intercontinental Medical Statistics (IMS) Health Canada. Of the 45,000 to 49,000 office-based physicians in Canada, IMS Health collected diagnosis-specific prescription diaries from a sample of 652, stratified according to geographic region and representing all major specialties, during this period.
RESULTS: Between 2002 and 2007, there were approximately 84,398 to 122,456 medically attended GH cases annually in Canada. Approximately 74% to 93% of these diagnosed cases made one physician visit per year. The annual rate of medically attended GH cases ranged from 261.2 per 100,000 population to 386.6 per 100,000 population. DISCUSSION: The present report is the first time that administrative data have been used to estimate the annual rate of medically attended GH cases in Canada. The data include both incident and prevalent cases and are likely an underestimate of the actual number of cases because they only represent diagnosed cases presenting for medical care. Further seroepidemiological and clinical research studies would be helpful to assess the burden of infection and to plan appropriate diagnostic, treatment and preventive counselling services.

Entities:  

Keywords:  Burden of HSV infection; Genital herpes; Herpes simplex virus; Physician visits; Rate of diagnosis

Year:  2012        PMID: 23450170      PMCID: PMC3374465          DOI: 10.1155/2012/386329

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  21 in total

1.  Herpes simplex virus type 2 in the United States, 1976 to 1994.

Authors:  D T Fleming; G M McQuillan; R E Johnson; A J Nahmias; S O Aral; F K Lee; M E St Louis
Journal:  N Engl J Med       Date:  1997-10-16       Impact factor: 91.245

Review 2.  The potential of UK clinical databases in enhancing paediatric medication research.

Authors:  Ian C K Wong; Macey L Murray
Journal:  Br J Clin Pharmacol       Date:  2005-06       Impact factor: 4.335

3.  Use of oseltamivir in 12 European countries between 2002 and 2007--lack of association with the appearance of oseltamivir-resistant influenza A(H1N1) viruses.

Authors:  P Kramarz; Dominique Monnet; A Nicoll; C Yilmaz; B Ciancio
Journal:  Euro Surveill       Date:  2009-02-05

4.  Herpes genitalis in patients attending a clinic for sexually transmitted diseases.

Authors:  D Lawee; M Gutman; M Hrytzay; J McLachlin
Journal:  Can Fam Physician       Date:  1983-02       Impact factor: 3.275

5.  Herpes simplex virus seroprevalence and risk factors in 2 Canadian sexually transmitted disease clinics.

Authors:  Ameeta E Singh; Barbara Romanowski; Tom Wong; Sita Gourishankar; Linda Myziuk; Jayne Fenton; Jutta K Preiksaitis
Journal:  Sex Transm Dis       Date:  2005-02       Impact factor: 2.830

6.  Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study.

Authors:  Rhonda Y Kropp; Thomas Wong; Louise Cormier; Allison Ringrose; Sandra Burton; Joanne E Embree; Marc Steben
Journal:  Pediatrics       Date:  2006-06       Impact factor: 7.124

7.  Diagnosing and treating premenstrual syndrome in five western nations.

Authors:  George Weisz; Loes Knaapen
Journal:  Soc Sci Med       Date:  2009-02-21       Impact factor: 4.634

8.  Maternal Herpes simplex virus type 2 infection, syphilis and risk of intra-partum transmission of HIV-1: results of a case control study.

Authors:  Frances M Cowan; Jean H Humphrey; Robert Ntozini; Kuda Mutasa; Rhoda Morrow; Peter Iliff
Journal:  AIDS       Date:  2008-01-11       Impact factor: 4.177

9.  Natural history of genital herpes simplex virus type 1 infection.

Authors:  Rebecca Engelberg; David Carrell; Elizabeth Krantz; Lawrence Corey; Anna Wald
Journal:  Sex Transm Dis       Date:  2003-02       Impact factor: 2.830

10.  Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada.

Authors:  Norm R C Campbell; Rollin Brant; Helen Johansen; Robin L Walker; Andreas Wielgosz; Jay Onysko; Ru-Nie Gao; Christie Sambell; Stephen Phillips; Finlay A McAlister
Journal:  Hypertension       Date:  2008-12-29       Impact factor: 10.190

View more
  2 in total

1.  Healthcare resource utilisation pattern and costs associated with herpes simplex virus diagnosis and management: a systematic review.

Authors:  Shaun Wen Huey Lee; Sami L Gottlieb; Nathorn Chaiyakunapruk
Journal:  BMJ Open       Date:  2022-01-04       Impact factor: 2.692

2.  Evidence-based circumcision policy for Australia.

Authors:  Brian J Morris; Athos Katelaris; Norman J Blumenthal; Mohamed Hajoona; Adrian C Sheen; Leslie Schrieber; Eugenie R Lumbers; Alex D Wodak; Phillip Katelaris
Journal:  J Mens Health       Date:  2022-05-30       Impact factor: 0.789

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.